Lung cancer is the most common cause of cancer death in men and women in North
America. A recent analysis of the Surveillance, Epidemiology and End Results database …

Although small-cell lung cancer (SCLC) once constituted 20%–25% of all newly diagnosed
lung cancers in North America, in recent years the incidence has decreased to less than …

Lung cancer is the most common cause of cancer death in men and women in North
America. A recent analysis of the Surveillance, Epidemiology and End Results database …

Small cell lung cancer (SCLC) was initially recognized as an entity distinct from other types
of lung cancer by pathologic examination in 1926 by Dr. Barnard [1]. It has been commonly …

Opinion statement Small cell lung cancer (SCLC) is an aggressive type of lung cancer
characterized by rapid growth and early metastasis. It is chemosensitive and radiosensitive …

Chemotherapy is currently the main treatment for all stages of small-cell lung cancer. In
extensive disease, etoposide/cisplatin (Platinol) is standard treatment, and in limited …

The incidence of small cell lung cancer (SCLC) is declining in the United States (US). SCLC
is nearly universally smoking-related and is very sensitive to both chemotherapy and …

There were approximately 42,000 new cases of small cell lung cancer (SCLC) in 2002.
Despite its initial sensitivity to chemotherapy, only 10% of all SCLC patients will have …

Purpose Small cell lung cancer (SCLC) historically has had poor prognosis. Clinical trials
have demonstrated improved survival among patients receiving standard platinum …

Small cell lung cancer (SCLC) occurs almost exclusively in smokers and represents 15 to
25% of all lung cancer histologic findings. It is distinguished from non-small cell lung cancer …